Silicon Valley Provides New Facility for Sunshine Heart
Sunshine Heart acquired a product line from a subsidiary of Baxter International. The company also closed a new $5 million facility with Silicon Valley Bank.
Sunshine Heart acquired a product line from a subsidiary of Baxter International. The company also closed a new $5 million facility with Silicon Valley Bank.
Aptevo Therapeutics, a biotechnology company focused on developing oncology and hematology therapeutics, has closed on a $35 million term loan agreement with MidCap Financial.
StoneMor Partners entered into a new $210 million revolving credit facility, representing a $30 million increase from its previous facility. Capital One was administrative agent and swingline lender.
Vivint Solar closed a $313 million term loan facility, arranged by Investec Bank, ING Capital, Silicon Valley Bank and SunTrust Robinson Humphrey as joint bookrunners.
The Middleby Corporation entered into a new $2.5 billion multi-currency senior revolving credit agreement with a lender group led by Bank of America as administrative agent.
EMCOR Group entered into a $1.3 billion credit agreement with a syndicate of banks led by Bank of Montreal as agent.
PNC Bank closed senior secured credit facilities totaling $48 million for two new clients: Wellnext, a family of nutritional supplements, and Elite One Source Nutrisciences, a manufacturer of supplements.
Heron Therapeutics closed an agreement with Tang Capital Partners to receive a loan up to $100 million with a two-year term that bears interest of 8% per annum.
Foundation Medicine secured a $100 million credit facility from Roche Finance.
Edge Therapeutics closed a $20 million dual-tranche term loan with Hercules Capital.